Parkinson's Disease Drugs Market, by Drug Class Thumbnail Image

2022

Parkinson's Disease Drugs Market, by Drug Class

Parkinson's Disease Drugs Market, by Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, COMT Inhibitors, MAO-B Inhibitors, Others), by Route of Administration (Oral, Injection, Transdermal), by Age Group (50 or below 50, Above 50 years): Global Opportunity Analysis and Industry Forecast, 2021 - 2031

LS : Healthcare

Select an option
Author's: Monika Darandale | Roshan Deshmukh
Publish Date: